AC Immune SA

NASDAQ:ACIU

2.1 (USD) • At close June 9, 2025
Bedrijfsnaam AC Immune SA
Symbool ACIU
Munteenheid USD
Prijs 2.1
Beurswaarde 207,780,510
Dividendpercentage 0%
52-weken bereik 1.43 - 4.93
Industrie Biotechnology
Sector Healthcare
CEO Dr. Andrea Pfeifer Ph.D.
Website https://www.acimmune.com

An error occurred while fetching data.

Over AC Immune SA

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are

Vergelijkbare Aandelen

Precigen, Inc. logo

Precigen, Inc.

PGEN

1.5 USD

ESSA Pharma Inc. logo

ESSA Pharma Inc.

EPIX

1.7 USD

Alpine Immune Sciences, Inc. logo

Alpine Immune Sciences, Inc.

ALPN

64.97 USD

Tenaya Therapeutics, Inc. logo

Tenaya Therapeutics, Inc.

TNYA

0.685 USD

AN2 Therapeutics, Inc. logo

AN2 Therapeutics, Inc.

ANTX

1.12 USD

Dyne Therapeutics, Inc. logo

Dyne Therapeutics, Inc.

DYN

14.4 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)